Laboratory control of heparin and heparin fragment treatment: an experimental study.
Doutremepuich
C
C
Laboratorie d'hématologie, Faculté de Pharmacie, Bordeaux, France.
Lalanne
M C
MC
Guyot
M
M
Doutremepuich
F
F
De Sèze
O
O
Toulemonde
F
F
D000818:Animals; D004353:Drug Evaluation, Preclinical; D065427:Factor Xa Inhibitors; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D008297:Male; D010314:Partial Thromboplastin Time; D011516:Prothrombin / Q000037:antagonists & inhibitors; D051381:Rats; D011919:Rats, Inbred Strains; D013924:Thrombophlebitis / Q000188:drug therapy
D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D011516:Prothrombin; C025337:Factor IIa; D006493:Heparin